Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis
Authors:
- 1 August 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 159 (5) , 1116-1123
Abstract
Background Psoriasis is a common dermatological disorder characterized by an immune‐mediated chronic inflammation which is associated with a variety of other diseases commonly referred to as comorbidities. The treatments for these diseases may interfere with the course and the treatment of psoriasis. Little is known on the general drug intake of patients with psoriasis. Objectives To gain more insight into the general drug intake of patients with severe psoriasis. A correlation of comedication to respective diseases could lead to a better knowledge of comorbidities. Methods Data on demographics, comedication and comorbidities from 1203 patients with severe psoriasis in Germany were analysed. As a control group data from 7099 subjects from the German National Health Survey 1998 were used. Results Patients with severe psoriasis are receiving significantly more different systemic drugs on average than the general population, with the most prominent difference in multidrug treatment. Drugs used in the treatment of arterial hypertension, diabetes mellitus and other diseases of the metabolic syndrome as well as oral anticoagulants and anticonvulsant agents showed the greatest differences. Special characteristics of antihypertensive drug treatments could be determined. Conclusions The data obtained in this study provide the basis for an improved management of patients with psoriasis. Knowledge of existing comedication and comorbidities may lead to the ability to treat psoriasis and comorbidities at the same time more safely and to use possible synergistic effects.Keywords
This publication has 20 references indexed in Scilit:
- Pathogenesis and clinical features of psoriasisThe Lancet, 2007
- The importance of disease associations and concomitant therapy for the long-term management of psoriasis patientsArchives of Dermatological Research, 2006
- Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasisArchives of Dermatological Research, 2006
- PSORS1: Linking Genetics and ImmunologyJournal of Investigative Dermatology, 2006
- Drug Exposure and Psoriasis Vulgaris: Case‐Control and Case‐Crossover StudiesActa Dermato-Venereologica, 2005
- The comorbid state of psoriasis patients in a university dermatology practiceJournal of Dermatological Treatment, 2005
- Prevalence of Joint Disease in Patients with PsoriasisAmerican Journal of Clinical Dermatology, 2003
- Drug-Induced PsoriasisAmerican Journal of Clinical Dermatology, 2000
- Disease concomitance in psoriasisJournal of the American Academy of Dermatology, 1995
- Angiotensin-converting enzyme inhibitors as possible exacerbating drugs in psoriasisJournal of the American Academy of Dermatology, 1993